These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28705401)

  • 1. [Are general practitioners in Paris and surrounding areas reticent about direct oral anticoagulants?].
    Caucanas C; Sfeir D; Blas-Châtelain C; Priollet P
    J Med Vasc; 2017 May; 42(3):133-140. PubMed ID: 28705401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.
    Huiart L; Ferdynus C; Renoux C; Beaugrand A; Lafarge S; Bruneau L; Suissa S; Maillard O; Ranouil X
    BMJ Open; 2018 Mar; 8(3):e018180. PubMed ID: 29602837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restraints to anticoagulation prescription in atrial fibrillation and attitude towards the new oral anticoagulants].
    Pereira-Da-Silva T; Souto Moura T; Azevedo L; Sá Pereira M; Virella D; Alves M; Borges L
    Acta Med Port; 2013; 26(2):127-32. PubMed ID: 23809744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulation in the aged patient with atrial fibrillation: What are prescribing cardiologists, geriatricians and general practitioners?].
    Fuchs P; Vogel T; Lang PO
    Rev Med Interne; 2015 Aug; 36(8):509-15. PubMed ID: 25956749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
    Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependency of prescribing patterns of oral anticoagulant drugs in Austria during 2011-2014.
    Schuh T; Reichardt B; Finsterer J; Stöllberger C
    J Thromb Thrombolysis; 2016 Oct; 42(3):447-51. PubMed ID: 27221106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
    Hum J; Shatzel JJ; Jou JH; Deloughery TG
    Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
    Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.
    Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N
    Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' and pharmacists' views and experiences regarding use of direct oral anticoagulants in clinical practice.
    Capiau A; Mehuys E; Dhondt E; De Backer T; Boussery K
    Br J Clin Pharmacol; 2022 Feb; 88(4):1856-1865. PubMed ID: 34625983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism.
    Brekelmans MP; Kappelhof M; Nieuwkerk PT; Nierman M; Buller HR; Coppens M
    Neth J Med; 2017 Mar; 75(2):50-55. PubMed ID: 28276323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.
    Mas Dalmau G; Sant Arderiu E; Enfedaque Montes MB; Solà I; Pequeño Saco S; Alonso Coello P
    BMC Fam Pract; 2017 Jan; 18(1):3. PubMed ID: 28086887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective study of the new oral anticoagulants in private practice: cautious optimism].
    Krieger C; Stephan D; Aleil B
    Ann Cardiol Angeiol (Paris); 2015 Apr; 64(2):68-75. PubMed ID: 25791799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".
    Ziakas PD; Kourbeti IS; Poulou LS; Vlachogeorgos GS; Mylonakis E
    PLoS One; 2018; 13(6):e0198674. PubMed ID: 29879194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Zirlik A; Bode C
    J Thromb Thrombolysis; 2017 Apr; 43(3):365-379. PubMed ID: 27896543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.